Concepedia

Marcelo Ramos Tejo Salgado

MR

Statistics

Publications

2

Citations

56

H-Index

2

Active since

2021

Affiliations

Roche (Canada)(Current)

Marcelo Ramos Tejo Salgado is an author at Roche (Canada) specializing in oncology, medicine, and colorectal cancer.

Publications per year

2021–2022

2

Publications

2

Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor–positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.

Peter A. Fasching, Aditya Bardia, Vanesa Quiroga et al. · Journal of Clinical Oncology · 2022 · 31 citations

, , +17

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study

Javier Sastre, Pilar García‐Alfonso, José María Viéitez et al. · ESMO Open · 2021 · 25 citations · Full text

, , +13

1–2 of 2